Routine maternal immunizations protect against severe infections without raising complication rates, according to new research published in Vaccine by Adelaide University and the Women’s and Children’s Health Network (WCHN).
The study analyzed data from nearly 19,000 pregnant women between 2020 and 2023. Researchers examined routine inoculations administered for influenza, pertussis, and COVID-19. They found no evidence linking these three vaccines to hypertensive disorders, chorioamnionitis, premature rupture of membranes, hemorrhage, or low birthweight. The World Health Organization estimates that 13.4 million babies were born early in 2020, making such premature births a leading cause of death in children under five, ThePrint reported.
“Receiving routine vaccinations such as the flu, pertussis and Covid-19 during pregnancy were in fact associated with more favorable birth outcomes,” said Dr Hassen Mohammed, a perinatal infectious-disease epidemiologist from Adelaide University’s School of Medicine.
Both influenza and whooping cough immunizations linked to a lower likelihood of obstetric complications. They reduced the risk of preterm birth by 13 percent and 17 percent respectively, while the COVID-19 vaccine delivered similar benefits, Mohammed told News-Medical.
Babies born to vaccinated mothers experienced better neonatal outcomes, including lower rates of resuscitation and early-onset sepsis.

“Our study found maternal vaccination was associated with improved fetal growth, with infants of vaccinated mothers weighing on average 90-180 g more and also being delivered several days later,” said Dr Prabha Andraweera, a maternal and child health expert from Adelaide University’s School of Medicine.
During the study period at Adelaide’s Women’s and Children’s Hospital, vaccine uptake varied among patients. Records show 64 percent of pregnant women received the influenza vaccine, 74 percent received the whooping cough vaccine, and 29.5 percent received the COVID-19 vaccine.
The Australian Immunisation Handbook notes that pregnant women face a higher risk of vaccine-preventable diseases like influenza, which can trigger premature delivery. Maternal antibodies cross the placenta to protect newborns during their first vulnerable months of life before their own immunizations begin.
The whooping cough vaccine also associated with a nearly 50 percent lower risk of stillbirth, echoing findings from other large cohort studies.
“This clear safety and efficacy evidence, supports maternal immunization as one of the most effective ways to prevent the potentially devastating outcomes of whooping cough, influenza and now also RSV, including death in newborn infants,” said Professor Helen Marshall AM, Professor of Vaccinology from Adelaide University’s School of Medicine and WCHN Clinical Research Director.
The research evaluated routine immunizations administered for influenza, pertussis, and COVID-19 among nearly 19,000 pregnant women.
The pertussis vaccine associated with a nearly 50 percent lower risk of stillbirth, according to findings published in Vaccine.
Between 2020 and 2023 at Adelaide’s Women’s and Children’s Hospital, 74 percent of pregnant women received the whooping cough vaccine, 64 percent received the flu vaccine, and 29.5 percent received the COVID-19 vaccine.
Antibodies from the mother travel through the placenta and remain active for the first few months of the baby’s life.
Keep reading